Lv11
86 积分 2022-10-30 加入
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
5小时前
已完结
Lighting the torch: intratumoural T cell-to-stroma enrichment score as a predictor of immunotherapy response in urothelial carcinoma
3个月前
已完结
Epigenetics in advanced renal cell carcinoma: Potential new targets
4个月前
已完结
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
4个月前
已完结
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials
4个月前
已完结
Targeting the tumour vasculature: from vessel destruction to promotion
4个月前
已完结
Resident memory T cells and cancer
7个月前
已完结
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer
8个月前
已完结
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab
8个月前
已完结
Exploring the next generation of antibody–drug conjugates
8个月前
已完结
皖公网安备34019202002308
